Balyasny Asset Management LLC Ptc Therapeutics, Inc. Transaction History

Balyasny Asset Management LLC

  • $58 Billion
  • Q3 2024

A detailed history of Balyasny Asset Management LLC transactions in Ptc Therapeutics, Inc. stock. As of the latest transaction made, Balyasny Asset Management LLC holds 62,549 shares of PTCT stock, worth $2.86 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
62,549
Holding current value
$2.86 Million
% of portfolio
0.0%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
BUY
$30.39 - $37.66 $1.9 Million - $2.36 Million
62,549 New
62,549 $2.32 Million
Q1 2023

May 15, 2023
SELL
$38.16 - $48.86 $362,367 - $463,974
-9,496 Reduced 9.41%
91,436 $4.43 Million
Q4 2022

Feb 14, 2023
BUY
$33.53 - $54.79 $3.38 Million - $5.53 Million
100,932 New
100,932 $3.85 Million
Q2 2022

Aug 15, 2022
SELL
$25.6 - $45.23 $2.8 Million - $4.95 Million
-109,402 Closed
0 $0
Q1 2022

May 16, 2022
BUY
$33.33 - $44.6 $865,913 - $1.16 Million
25,980 Added 31.14%
109,402 $4.08 Million
Q4 2021

Feb 14, 2022
SELL
$35.36 - $41.86 $879,403 - $1.04 Million
-24,870 Reduced 22.97%
83,422 $3.32 Million
Q3 2021

Nov 15, 2021
SELL
$37.01 - $44.74 $5.05 Million - $6.11 Million
-136,540 Reduced 55.77%
108,292 $4.03 Million
Q2 2021

Aug 16, 2021
BUY
$37.95 - $49.37 $9.29 Million - $12.1 Million
244,832 New
244,832 $10.3 Million
Q4 2020

Feb 16, 2021
SELL
$47.96 - $67.64 $263,252 - $371,275
-5,489 Closed
0 $0
Q3 2020

Nov 16, 2020
SELL
$45.41 - $57.07 $95,769 - $120,360
-2,109 Reduced 27.76%
5,489 $257,000
Q2 2020

Aug 14, 2020
BUY
$42.56 - $54.98 $323,370 - $417,738
7,598 New
7,598 $386,000
Q4 2019

Feb 14, 2020
SELL
$32.22 - $50.07 $3 Million - $4.66 Million
-93,122 Closed
0 $0
Q3 2019

Nov 14, 2019
BUY
$33.82 - $48.17 $104,300 - $148,556
3,084 Added 3.43%
93,122 $3.15 Million
Q2 2019

Aug 14, 2019
SELL
$35.42 - $45.0 $2.43 Million - $3.09 Million
-68,713 Reduced 43.28%
90,038 $4.05 Million
Q1 2019

May 15, 2019
BUY
$28.09 - $39.49 $4.46 Million - $6.27 Million
158,751 New
158,751 $5.98 Million
Q4 2018

Feb 14, 2019
SELL
$29.83 - $46.51 $20.9 Million - $32.6 Million
-700,692 Closed
0 $0
Q3 2018

Nov 14, 2018
BUY
$33.9 - $47.77 $13.3 Million - $18.8 Million
392,931 Added 127.67%
700,692 $32.9 Million
Q2 2018

Aug 14, 2018
BUY
$25.7 - $47.88 $2.09 Million - $3.89 Million
81,228 Added 35.86%
307,761 $10.4 Million
Q1 2018

May 15, 2018
BUY
$17.46 - $32.59 $3.96 Million - $7.38 Million
226,533 New
226,533 $6.13 Million
Q4 2017

Feb 14, 2018
SELL
$15.14 - $20.89 $228,614 - $315,439
-15,100 Closed
0 $0
Q3 2017

Nov 14, 2017
BUY
$16.81 - $21.61 $253,830 - $326,311
15,100
15,100 $302,000

Others Institutions Holding PTCT

# of Institutions
221
Shares Held
78.1M
Call Options Held
144K
Put Options Held
58.7K
View Full List

About PTC THERAPEUTICS, INC.

PTCT Quotes by TradingView
  • Ticker PTCT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 71,541,000
  • Market Cap $3.27B
  • Description
  • PTC Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines to patients with rare disorders. Its portfolio pipeline includes commercial products and product candidates in various stages of development, including clinical, pre-clinical and research and discovery stages, focuses on...
More about PTCT
Track This Portfolio

Track Balyasny Asset Management LLC Portfolio

Follow Balyasny Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Balyasny Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Balyasny Asset Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email